Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Cancer Invest ; 38(7): 394-405, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32643440

ABSTRACT

The study investigated the human cytomegalovirus (HCMV) and human papillomavirus (HPV) in gliomas. A retrospective study was conducted on 112 samples. HCMV was investigated by PCR, in situ hybridization (ISH) and immunohistochemistry. HPV was tested by PCR and DNA ISH. HCMV was identified in 60 gliomas, including 55 GBM. However, RNA ISH and immunohistochemistry failed to detect HCMV positivity. HPV was identified in 44 GBM. No significant relationship was identified between HCMV and HPV and tumour characteristics (p > 0.05). Our findings support the HCMV and HPV presence in gliomas. Further assays are required to more explore the potential efficient antiviral management.


Subject(s)
Brain Neoplasms/virology , Cytomegalovirus/isolation & purification , Glioma/virology , Papillomaviridae/isolation & purification , Adult , Aged , Brain Neoplasms/mortality , Brain Neoplasms/pathology , Cytomegalovirus/genetics , Cytomegalovirus Infections/virology , Female , Glioma/mortality , Glioma/pathology , Humans , Immunohistochemistry , Kaplan-Meier Estimate , Male , Middle Aged , Papillomaviridae/genetics , Papillomavirus Infections/virology , Polymerase Chain Reaction , Retrospective Studies , Tunisia , Young Adult
2.
J Neurovirol ; 26(3): 347-357, 2020 06.
Article in English | MEDLINE | ID: mdl-32124265

ABSTRACT

The gliomagenesis remains not fully established and their etiological factors still remain obscure. Polyomaviruses were detected and involved in several human tumors. Their potential implication in gliomas has been not yet surveyed in Africa and Arab World. Herein, we investigated the prevalence of six polyomaviruses (SV40, JCPyV, BKPyV, MCPyV, KIPyV, and WUPyV) in 112 gliomas from Tunisian patients. The DNA sequences of polyomaviruses were examined by PCR assays. Viral infection was confirmed by DNA in situ hybridization (ISH) and/or immunohistochemistry (IHC). The relationships between polyomavirus infection and tumor features were evaluated. Specific SV40 Tag, viral regulatory, and VP1 regions were identified in 12 GBM (10.7%). DNA ISH targeting the whole SV40 genome and SV40 Tag IHC confirmed the PCR findings. Five gliomas yielded JCPyV positivity by PCR and DNA ISH (2.7%). However, no BKPyV, KIPyV, and WUPyV DNA sequences were identified in all samples. MCPyV DNA was identified in 30 gliomas (26.8%). For GBM samples, MCPyV was significantly related to patient age (p = 0.037), tumor recurrence (p = 0.024), and SV40 (p = 0.045) infection. No further significant association was identified with the remaining tumor features (p > 0.05) and patient survival (Log Rank, p > 0.05). Our study indicates the presence of SV40, JCPyV, and MCPyV DNA in Tunisian gliomas. Further investigations are required to more elucidate the potential involvement of polyomaviruses in these destructive malignancies.


Subject(s)
Brain Neoplasms/virology , Glioma/virology , JC Virus/genetics , Merkel cell polyomavirus/genetics , Neoplasm Recurrence, Local/virology , Polyomavirus Infections/virology , Simian virus 40/genetics , Adult , Age Factors , Brain Neoplasms/genetics , Brain Neoplasms/mortality , Brain Neoplasms/pathology , Capsid Proteins/genetics , Capsid Proteins/metabolism , DNA, Viral/genetics , DNA, Viral/metabolism , Female , Follow-Up Studies , Glioma/genetics , Glioma/mortality , Glioma/pathology , Humans , Immunohistochemistry , In Situ Hybridization , JC Virus/growth & development , JC Virus/pathogenicity , Male , Merkel cell polyomavirus/growth & development , Merkel cell polyomavirus/pathogenicity , Middle Aged , Neoplasm Grading , Neoplasm Recurrence, Local/genetics , Neoplasm Recurrence, Local/mortality , Neoplasm Recurrence, Local/pathology , Polyomavirus Infections/genetics , Polyomavirus Infections/mortality , Polyomavirus Infections/pathology , Simian virus 40/growth & development , Simian virus 40/pathogenicity , Survival Analysis , Viral Load
3.
Mol Neurobiol ; 54(4): 2381-2394, 2017 05.
Article in English | MEDLINE | ID: mdl-26957305

ABSTRACT

It has become increasingly evident that morphologically similar gliomas may have distinct clinical phenotypes arising from diverse genetic signatures. To date, glial tumours from the Tunisian population have not been investigated. To address this, we correlated the clinico-pathology with molecular data of 110 gliomas by a combination of HM450K array, MLPA and TMA-IHC. PTEN loss and EGFR amplification were distributed in different glioma histological groups. However, 1p19q co-deletion and KIAA1549:BRAF fusion were, respectively, restricted to Oligodendroglioma and Pilocytic Astrocytoma. CDKN2A loss and EGFR overexpression were more common within high-grade gliomas. Furthermore, survival statistical correlations led us to identify Glioblastoma (GB) prognosis subtypes. In fact, significant lower overall survival (OS) was detected within GB that overexpressed EGFR and Cox2. In addition, IDH1R132H mutation seemed to provide a markedly survival advantage. Interestingly, the association of IDHR132H mutation and EGFR normal status, as well as the association of differentiation markers, defined GB subtypes with good prognosis. By contrast, poor survival GB subtypes were defined by the combination of PTEN loss with PDGFRa expression and/or EGFR amplification. Additionally, GB presenting p53-negative staining associated with CDKN2A loss or p21 positivity represented a subtype with short survival. Thus, distinct molecular subtypes with individualised prognosis were identified. Interestingly, we found a unique histone mutation in a poor survival young adult GB case. This tumour exceptionally associated the H3F3A G34R mutation and MYCN amplification as well as 1p36 loss and 10q loss. Furthermore, by exhibiting a remarkable methylation profile, it emphasised the oncogenic power of G34R mutation connecting gliomagenesis and chromatin regulation.


Subject(s)
Brain Neoplasms/classification , Brain Neoplasms/diagnosis , Glioma/classification , Glioma/diagnosis , Pathology, Molecular , Adolescent , Adult , Aged , Biomarkers, Tumor/metabolism , Brain Neoplasms/genetics , Brain Neoplasms/therapy , Child , Child, Preschool , Cluster Analysis , Cohort Studies , DNA Methylation/genetics , Epigenesis, Genetic , Female , Glioma/genetics , Glioma/therapy , Humans , Immunohistochemistry , Infant , Kaplan-Meier Estimate , Male , Middle Aged , Prognosis , Survival Analysis , Tissue Array Analysis , Tunisia , Young Adult
5.
Asian Pac J Cancer Prev ; 16(16): 6871-6, 2015.
Article in English | MEDLINE | ID: mdl-26514459

ABSTRACT

BACKGROUND: The meningeal hemangiopericytoma (MHPC) is a vascular tumor arising from pericytes. Most intracranial MHPCs resemble meningiomas (MNGs) in their clinical presentation and histological features and may therefore be misdiagnosed, despite important differences in prognosis. MATERIALS AND METHODS: We report 8 cases of MHPC and 5 cases of MNG collected from 2007 to 2011 from the Neuro-Surgery and Histopathology departments. All 13 samples were re reviewed by two independent pathologists and investigated by immunohistochemistry (IHC) using mesenchymal, epithelial and neuro-glial markers. Additionally, we screened all tumors for a large panel of chromosomal alterations using multiplex ligation probe amplification (MLPA). Presence of the NAB2-STAT6 fusion gene was inferred by immunohistochemical staining for STAT6. RESULTS: Compared with MNG, MHPCs showed strong VIM (100% of cases), CD99 (62%), bcl-2 (87%), and p16 (75%) staining but only focal positivity with EMA (33%) and NSE (37%). The p21 antibody was positive in 62% of MHPC and less than 1% in all MNGs. MLPA data did not distinguish HPC from MNG, with PTEN loss and ERBB2 gain found in both. By contrast, STAT6 nuclear staining was observed in 3 MHPC cases and was absent from MNG. CONCLUSIONS: MNG and MHPC comprise a spectrum of tumors that cannot be easily differentiated based on histopathology. The presence of STAT6 nuclear positivity may however be a useful diagnostic marker.


Subject(s)
Hemangiopericytoma/chemistry , Hemangiopericytoma/genetics , Meningeal Neoplasms/chemistry , Meningeal Neoplasms/genetics , Meningioma/chemistry , Meningioma/genetics , 12E7 Antigen , Adolescent , Adult , Aged , Aged, 80 and over , Antigens, CD/analysis , Cell Adhesion Molecules/analysis , Cyclin-Dependent Kinase Inhibitor p16/analysis , Cyclin-Dependent Kinase Inhibitor p16/genetics , ErbB Receptors/genetics , Female , Hemangiopericytoma/pathology , Humans , Immunohistochemistry , Male , Meningeal Neoplasms/pathology , Meningioma/pathology , Middle Aged , Multiplex Polymerase Chain Reaction , PTEN Phosphohydrolase/genetics , Proto-Oncogene Proteins c-bcl-2/analysis , Receptor, ErbB-2/genetics , STAT6 Transcription Factor/analysis , Tumor Suppressor Protein p53/genetics , Vimentin/analysis
6.
Asian Pac J Cancer Prev ; 15(20): 8753-7, 2014.
Article in English | MEDLINE | ID: mdl-25374202

ABSTRACT

BACKGROUND: Glioma is a heterogeneous central nervous system (CNS) tumor group that encompasses different histological subtypes with high variability in prognosis. The lesions account for almost 80% of primary malignant brain tumors. The aim of this study is to extend our understanding of the glioma epidemiology in the central Tunisian region. MATERIALS AND METHODS: We analyzed 393 gliomas recorded in cancer registry of central Tunisia from 1993 to 2012. Crude incidence rates (CR) and world age-standardized rates (ASR) were estimated using annual population data size and age structure. Statistic correlations were established using Chi-square and Kaplan-Meier test. RESULTS: Tunisian glioma patients were identified with a mean age at diagnosis of 48 years and 1.5 sex ratio (male/female). During the 19 years period of study the highest incidence value was observed in male group between 1998 and 2002 (CR: 0.28, ASR: 0.3). Incidence results underline increasing high grade glioma occurring in the adulthood in the last period (2007-2012). Median survival was 27 months, with 1-, 2- and 5-year survival rates of 42%, 30% and 26%, respectively. Survival was greater in patients with younger age, lower tumor grade, infratentrial tumor location and undergoing a palliative treatment. CONCLUSIONS: This central Tunisia gliomas registry study provides important information that could improve glioma management and healthcare practice.


Subject(s)
Brain Neoplasms/epidemiology , Glioma/epidemiology , Registries , Adolescent , Adult , Age Distribution , Aged , Aged, 80 and over , Brain Neoplasms/pathology , Brain Neoplasms/therapy , Chi-Square Distribution , Developing Countries , Disease-Free Survival , Female , Glioma/pathology , Glioma/therapy , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Prevalence , Prognosis , Retrospective Studies , Sex Distribution , Survival Analysis , Tunisia/epidemiology , Young Adult
7.
J Neuroradiol ; 41(4): 243-50, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24238840

ABSTRACT

PURPOSE: Three cases of histopathologically confirmed central neurocytoma (CN) are presented, emphasizing diagnostic imaging issues: conventional magnetic resonance imaging with Proton magnetic resonance spectroscopy (MRS) and diffusion-weighted imaging (DWI) findings of CN. MATERIALS AND METHODS: Patients age ranged from 17 to 32 years, Imaging include a CT scan and MR examination with DWI and proton MRS on a 1.5-T system. DWI and subsequent apparent diffusion coefficient (ADC) were obtained in all. Single voxel MRS was performed prior to surgery using a point resolved spectroscopy sequence (PRESS) with short 35 ms and long echotime (TE) 144 ms, associated with a two-dimensional chemical Shift Imaging (2D-CSI) with 144 ms TE (one case). Histopathological examination included immunostaining with synaptophysin. RESULTS: With the long TE, a variable amount of glycine with markedly increased choline, very small to almost complete loss of N-acetylaspartate and creatine, and inverted triplet of alanine-lactate were observed in all three patients. Increased glutamate and glutamine complex (Glx) was also observed in all with short TE. DWI demonstrated variable low ADC which appeared well correlated with the tumor signal intensity and cell density: the most homogeneous and highly dense cellular tumor with increased nucleus to cytoplasm ratio demonstrated the lower ADC. Histological pattern was typical in two cases and demonstrated an oligodendroglioma-like pattern in one case. Positivity for synaptophysin confirmed the neuronal origin in all. CONCLUSION: The demonstration within an intraventricular tumor of both glycine and alanine on MRS along with high choline, bulky Glx and restricted diffusion appear diagnostic of CN.


Subject(s)
Brain Neoplasms/chemistry , Brain Neoplasms/pathology , Diffusion Magnetic Resonance Imaging/methods , Neurocytoma/chemistry , Neurocytoma/pathology , Neurotransmitter Agents/analysis , Proton Magnetic Resonance Spectroscopy/methods , Adolescent , Adult , Biomarkers/analysis , Female , Humans , Male , Reproducibility of Results , Sensitivity and Specificity , Young Adult
8.
Turk Neurosurg ; 22(4): 461-4, 2012.
Article in English | MEDLINE | ID: mdl-22843466

ABSTRACT

Oligodendrogliomas are the tumors of normal glial cells of brain called oligodendrocytes. They represent a small proportion of childhood brain tumors and are infrequently encountered in the posterior fossa. CT scan and MRI are very helpful for the preoperative management of oligodendrogliomas. However, due to the rarity and non-specific imaging features, it may be difficult to differentiate oligodendroglioma from astrocytoma especially in an infratentorial location. The short- and long-term outcome and the exact treatment protocol of posterior fossa oligodendroglioma is yet to be established. We report a rare case of an oligodendroglioma of the vermis in an 8-year-old female with a brief review of the literature.


Subject(s)
Infratentorial Neoplasms/surgery , Oligodendroglioma/surgery , Brain/diagnostic imaging , Brain/pathology , Child , Humans , Hydrocephalus/etiology , Infratentorial Neoplasms/pathology , Magnetic Resonance Imaging , Male , Nervous System Diseases/etiology , Neurologic Examination , Oligodendroglioma/pathology , Tomography, X-Ray Computed , Treatment Outcome
9.
Infect Dis Rep ; 1(1): e5, 2009 Sep 14.
Article in English | MEDLINE | ID: mdl-24470883

ABSTRACT

Salmonella focal intracranial infections are reported rarely. They tend to occur in immunocompromised patients. We present here a case of Salmonella typhimurium epidural empyema, with osteomyelitis of the adjacent frontal bone, in a 37-year-old human immunodeficiency virus positive man who presented with a three-day history of headache, fever, and sweats. He was treated successfully with antibiotics and surgical drainage.

10.
Tunis Med ; 86(4): 383-5, 2008 Apr.
Article in English | MEDLINE | ID: mdl-19476144

ABSTRACT

We report a rare case of intradural immature teratoma in 2-year-old girl, interesting conus medullaris to sacrum, worsening neurological deficits. The neoplasm discovered by magnetic resonance imaging, was completely resected. We describe the clinical, radiological and pathological findings of this tumor with a review of the Literature and we insist in the difficulty of treatment.


Subject(s)
Spinal Neoplasms , Teratoma , Child, Preschool , Female , Humans , Spinal Neoplasms/diagnosis , Spinal Neoplasms/surgery , Teratoma/diagnosis , Teratoma/surgery
11.
Tunis Med ; 85(2): 166-9, 2007 Feb.
Article in French | MEDLINE | ID: mdl-17665668

ABSTRACT

BACKGROUND: Spinal epidermoid cysts are rare tumors and they are exceptionally intramedullary. AIM: Report of news cases CASE REPORT: The diagnosis is established by magnetic resonance imaging and the treatment is surgical. The prognosis is generally good, with possible recurrence after many years. The author report five new cases of intramedullary epidermoide cysts operated between 1996 and 2001.


Subject(s)
Epidermal Cyst/diagnosis , Spinal Cord Diseases/diagnosis , Adult , Child , Child, Preschool , Epidermal Cyst/surgery , Female , Humans , Magnetic Resonance Imaging , Male , Spinal Cord Diseases/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...